Bills › 91st General Assembly
Relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties
Sponsored by Rep. John H. Wills (R)
Topics:Alcohol, cannabis & gamingState governmentHealth care
Same legislation: HF 978
Where it is now
- Done: IntroducedFebruary 26, 2025
- Done: SubcommitteeMarch 18, 2025
- Done: House committeeMarch 27, 2025
- Skipped: Passes the HouseContinued as HF 978
- Next: Senate committee
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Became HF 978 → Its progress continues under the new number. Go to HF 978 What’s a funnel?
Amendments · 2
1 adopted · 0 failed · 1 never voted on. Newest first.
- S-5119 · filed March 19, 2026 byNever voted onAI summary This amendment changes the effective year of the bill and updates the medical cannabidiol board to include members with expertise in psilocybin, mushroom cultivation, and research manufacturing. It also requires that patients receiving psilocybin have verified post-traumatic stress disorder and establishes rules for transferring the existing cannabidiol board's duties, funds, and files to the new licensing board.
- H-1260 · filed April 21, 2025 byAdoptedAI summary This amendment removes the requirement to notify the state about changes in ownership interest and allows the board to issue provisional licenses to businesses that have not yet secured a location. It adds protections to prevent child removal from a home based solely on authorized psilocybin use, permits the sale of psilocybin consumable goods, and ensures that contracts related to psilocybin are legally enforceable despite federal laws. Additionally, it directs the department of health and human services to study the use of other psychedelic compounds for medical conditions.April 21, 2025